drugset / Trial / NCT02157558
An Open-Label Drug-Drug Interaction Study of Telotristat Etiprate and Fexofenadine in Healthy Subjects
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to evaluate the effects of steady-state telotristat ethyl on the pharmacokinetics (PK) of single-dose fexofenadine in healthy subjects.
Timeline
- Start
- 2014-07
- Primary completion
- 2014-08
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Fexofenadine | Unknown | 180 mg | Oral |
| Subject | Telotristat etiprate | Unknown | 500 mg | Oral |
Indications
No indication recorded.